MAPT and Alzheimer disease: The loss of inhibitory GABAergic interneurons resulting in network hyperactivity may be a key driver of neurodegeneration in AD by stimulating the spread of amyloid and tau pathology, which in turn promotes excitotoxicity and cell death [28].